9xchange Joins Forces With BenevolentAI to Integrate Its AI Technology Into Its Innovative Biopharma Marketplace
TEL AVIV, Israel--(BUSINESS WIRE)--9xchange, a biopharma marketplace created for innovators to match, buy and sell drug assets, today announces it has partnered with BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leading AI-enabled drug discovery and development company. The partnership aims to leverage BenevolentAI's AI-enabled technology to support decision-making...
